Aging is the major risk factor for most human diseases and affects every single individual in the world. The development of novel strategies to extend human healthspan and lifespan is currently a rapidly growing area of research and might represent one of the best investment opportunities from a philanthropic and business perspective.
Swiss Francs (CHF) in funding
Public funding sources
Swiss National Science Foundation
Novartis Foundation for Medical-Biological Research
Canton de Vaud
Fondation Pierre Mercier pour la Science
Université de Lausanne
Collaborations with industry
You can now participate in accelerating the development of the next generation of anti-aging therapies by supporting some of our research projects.